Brief: Nexalin Technology Announces Positive Results of Clinical Study Evaluating Its Gen-2 tACS Device

Nexalin Technology

28/03/2024 15:05

March 28 (Reuters) - Nexalin Technology Inc  NXL.O :
    * NEXALIN TECHNOLOGY ANNOUNCES POSITIVE RESULTS OF CLINICAL
STUDY
VALIDATING ITS GEN-2 TACS DEVICE FOR REDUCING PAIN AMONG
VETERANS WITH MILD TRAUMATIC BRAIN INJURY AT UNIVERSITY OF
CALIFORNIA, SAN DIEGO
    * NEXALIN TECHNOLOGY INC - STUDY INVOLVING VA AND UCSD
ACHIEVED
STATISTICALLY SIGNIFICANT DECREASE IN PCS AND PTSD SYMPTOMS

Source text for Eikon:  ID:nGNE2Db1l3 
Further company coverage:  NXL.O 

 ((Reuters.Briefs@thomsonreuters.com;))